Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

17.98
Delayed Data
As of 4:01pm ET
 +0.70 / +4.05%
Today’s Change
14.59
Today|||52-Week Range
25.96
+16.60%
Year-to-Date

Today’s Trading

Previous close17.28
Today’s open17.51
Day’s range17.46 - 18.05
Volume17,817,502
Average volume (3 months)11,112,756
Market cap$22.5B
Data as of 4:01pm ET, 02/15/2019

Growth & Valuation

Earnings growth (last year)-23,426.50%
Earnings growth (this year)-27.03%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+2.60%
P/E ratioNM
Price/Sales0.85
Price/Book1.63

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd-2.46-1.83%
AKRXAkorn Inc+0.11+2.54%
OASMOasmia Pharmaceutica...+0.08+3.18%
Data as of 4:00pm ET, 02/15/2019

Financials

Last reporting dateFebruary 14, 2019
EPS forecast (this quarter)$0.55
Annual revenue (last year)$22.5B
Annual profit (last year)-$16.4B
Net profit margin-72.66%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Kåre Schultz
Executive Vice President-
Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Hamerkaz

Forecasts